DMC Global Inc. (BOOM) as of March 31, 2026 presents a deeply negative liquidation recovery posture for common equity, driven primarily by the structural mismatch between a large intangibles-heavy balance sheet and face-value liabilities that include a material redeemable noncontrolling interest obligation. Total GAAP assets of $648.4M are dominated by items that receive zero or steeply discounted recovery value under a liquidation lens: finite-lived intangibles of $150.7M (net) receive 0%; goodwill embedded within OtherAssetsNoncurrent would similarly be worthless; and PP&E net of $124.4M faces a 50-70% haircut. Working through the asset side: cash of $31.5M recovers at 100% (~$31.5M); gross AR of $100.7M (net $90.9M after $9.9M allowance) recovers at 90-95% (~$86-96M); inventory of $167.0M recovers at 60% (~$100M); PP&E gross $248.6M less accumulated depreciation $124.2M = $124.4M net, recovering at 50-70% (~$62-87M); finite-lived intangibles net $150.7M receive 0%; operating lease ROU assets $43.2M receive 0% in a liquidation context. Total estimated asset recovery: roughly $280-315M. On the liability side at face value: total liabilities of $226.1M including $55.2M credit facility debt, $47.3M operating lease obligations (which do not extinguish on windup), and $27.0M deferred revenue. Critically, the $187.1M redeemable NCI (the Arcadia Products 40% minority put/call obligation) sits above common equity in the capital structure and must be settled before any equity recovery. Combined claims against assets: $226.1M total liabilities plus $187.1M redeemable NCI = ~$413M in senior claims against ~$280-315M in recoverable assets. This yields a negative recovery to common equity of approximately -$98M to -$133M, consistent with MFFAIS CLV of -$183M and LLV of -$93M. The quarter saw material deterioration in operating performance: net sales fell 15% YoY to $135.6M, consolidated gross margin compressed from 25.9% to 18.8%, and the company generated an operating loss of $4.1M versus operating income of $6.5M in Q1 2025. Net cash used in operations was $2.4M, with inventory increasing $22.9M QoQ as all three segments built stock in anticipation of improved activity. Funded debt increased to $55.2M from approximately $51.9M at December 31, 2025, as $3.2M net revolver draws funded incentive compensation payments. The redeemable NCI Put Option, exercisable on or after September 6, 2026, at a formula-derived value currently disclosed as $187.1M (net of a $24.9M promissory note receivable from the NCI holder), represents the single largest contingent liability and the primary driver of negative equity recovery. Filing discusses the tariff refund potential in MD&A (U.S. Supreme Court IEEPA ruling) but does not separately tag it in XBRL; no refund receivable has been recorded. NobelClad product performance issue disclosed in contingencies without an accrual; exposure is unquantified.
▼ Community Notes